Three ways we work with you
We don't describe services — we deliver outcomes. Here's what you get.
We actively scan the European market for products that match your portfolio criteria — generics, OTC, or specialty. You get a structured opportunity report every month with commercial, regulatory and supply assessment included.
- Shortlisted opportunities with scoring
- Initial partner outreach handled
- Commercial and patent pre-screening
From MA strategy to first sale — we manage the full Nordic market entry for your product. Regulatory pathway, distributor selection, pricing, channel setup and launch plan. One point of contact. Fixed scope.
- Full Nordic regulatory strategy
- Distributor and partner identification
- Launch plan with KPIs and timeline
We represent a growing portfolio of licensed pharma products and actively seek the right distribution partners across Europe. If you're looking for new products to add to your portfolio, we source and structure the deal — from first contact to signed agreement.
- Curated portfolio of out-licensing opportunities
- Partner identification and commercial negotiation
- Success fee model — we earn when you do
Dan Kyster Hartwig
Founder · DH Nordic Pharma Consultancy
15+ years as Head of Business Development at two of Denmark's largest generics companies — Orifarm Generics and 2care4. Closed licensing, supply and asset deals across Europe and Asia. Member of the board at Orifarm Group.
Today I work as a fractional BD partner for pharma companies that need senior execution without a full-time hire.
Ready to talk?
A 30-minute call costs nothing. Let's find out if we're a fit.